Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review

Author:

Yogeeta Fnu1,Rauf Sameer Abdul1,Devi Muskan1,Imran Komal1,Ahmed Rubayyi1,Aruwani Prashant K.1,Saad Muhammad1,Tooba Fnu1,Hashmani Faiza Zehra1,Ibrahim Mufliha1,Kumar Neeraj1,Shah Hussain Haider2,Hussain Tooba2,Haque Md Ariful345

Affiliation:

1. Department of Internal Medicine, Liaquat National Medical College

2. Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan

3. Department of Public Health, Atish Dipankar University of Science and Technology

4. Voice of Doctors Research School, Dhaka, Bangladesh

5. Department of Orthopaedic Surgery, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China

Abstract

This narrative review provides a succinct exploration of prolactinoma, the most common pituitary adenoma, focusing on its epidemiology, clinical manifestations, and therapeutic interventions. Beginning with an overview of its prevalence and aetiology, the review delves into the gender distribution and familial associations of prolactinoma. Clinical presentations, including endocrine disruptions, reproductive health issues, and metabolic disturbances, are examined, emphasizing their impact on hormonal regulation and cardiovascular health. The narrative then navigates through pharmacological treatments, surgical interventions, and radiation therapy, highlighting their efficacy, side effects, and long-term management challenges. Strategies to mitigate side effects and optimize treatment outcomes are discussed, emphasizing the importance of multidisciplinary collaboration in prolactinoma management. This review is a concise yet comprehensive resource for healthcare professionals and researchers, providing insights into prolactinoma’s clinical complexities and therapeutic nuances to guide optimal patient care strategies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference87 articles.

1. The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best practice & research;Chanson;Clin Endocrinol Metab,2019

2. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium;Daly;J Clin Endocrinol Metab,2006

3. Hypeprolactinemia: still an insidious diagnosis;Aliberti;Endocrine,2020

4. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline;Melmed;J Clin Endocrinol Metab,2011

5. Prolactinomas in males: any differences?;Duskin-Bitan;Pituitary,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3